Key result
Preoperative CT-measured sarcopenic obesity was significantly associated with an increased risk of anastomotic leak (OR 2.95) following elective colon resection for non-metastatic colon cancer.
Why the study?
The study aimed to investigate the influence of sarcopenic obesity on anastomotic leak, overall morbidity, mortality, and length of hospital stay following elective colon resection for non-metastatic colon cancer.
Does CT-measured sarcopenic obesity increase the risk of anastomotic leak and other postoperative complications in patients undergoing elective colon resection for non-metastatic colon cancer?
Observational (n=544)
No
Does CT-measured sarcopenic obesity increase the risk of anastomotic leak and other postoperative complications in patients undergoing elective colon resection for non-metastatic colon cancer?
CT-measured sarcopenic obesity is an independent predictor of increased morbidity, mortality, and anastomotic leak following elective colon cancer surgery.
Sarcopenic obesity was associated with anastomotic leak and higher morbidity after colon resection; leaves open whether preoperative body-composition assessment should guide risk stratification.
OBJECTIVE: This study aimed to investigate the influence of sarcopenic obesity on anastomotic leak following elective colon resection for non-metastatic colon cancer. Secondary outcomes included overall morbidity, mortality and length of hospital stay. METHODS: This retrospective observational study, conducted at a colorectal surgery referral centre, spanned from January 1, 2015, to January 1, 2020. A total of 544 consecutive patients who underwent elective colon resection were included in the analysis, excluding patients with rectal cancer, urgent surgery, absence of anastomosis, lack of imaging, multivisceral resections and synchronic tumours. RESULTS: Postoperative complications were observed in 177 (32.3%) patients, with 51 (9.31%) classified as severe (Clavien-Dindo > II). Sarcopenic obesity was identified in 9.39% of the sample and emerged as an independent predictor of increased overall morbidity [OR 2.15 (1.14-3.69); p = 0.016] and 30-day mortality [OR 5.07 (1.22-20.93); p = 0.03] and was significantly associated with the development of anastomotic leak [OR 2.95 (1.41-6.18); p = 0.007]. Furthermore, it increased the risk of reoperation and was linked to a prolonged length of hospital stay. CONCLUSIONS: CT-measured sarcopenic obesity demonstrates a discernible correlation with an elevated risk of postoperative morbidity and mortality in the context of colon cancer surgery.
No takes yet. Share an insight, caveat, or question.
Bajawi et al. (2024) conducted an observational in Non-metastatic colon cancer (n=544). CT-measured sarcopenic obesity vs. Absence of sarcopenic obesity was evaluated on Anastomotic leak (OR 2.95, 95% CI 1.41-6.18, p=0.007). Preoperative CT-measured sarcopenic obesity was significantly associated with an increased risk of anastomotic leak (OR 2.95) following elective colon resection for non-metastatic colon cancer.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: